Pipeline map including
next generation Matrix Therapies with RGTA®
liseret1
liseret2
liseret1

Clinical Pipeline

Clinical Pipeline

1_Pipeline_Desktop
3_Pipeline_Mobile
logo_o

OTR3 focuses on high potential programs
including award winning key projects.

Preclinical Pipeline

Preclinical Pipeline

OTR3 focuses on key development projects with high potential, with the aim of exploiting the versatility of the RGTA® technology to provide to patients new healthcare products that really matter.

The following development programs, relying on the regenerating potential of RGTA® molecules,  are just only a fraction of the technology’s potential, and are to date the closer to market.

The excellence and potential of OTR3’s Pipeline has been confirmed by awards and grants (H2020 SME Instrument, Medicen Label, ANR grant, INCA)

Neurology
liseret2
liseret1
Pipeline
Pipeline

Organes Tissus Regeneration Reparation Remplacement

© 2022 – OTR3 – All rights reserved

ADDRESS

4, rue Française
75001 Paris, France

© 2022 – OTR3 – All rights reserved